España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Kaleido Biosciences
KLDO
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.000100
0
0.00%
At close: -
$~0
~0
-99.00%
After Hours: Feb 20, 4:15 PM EDT
Get Report
Comment
Kaleido Biosciences (KLDO) Forecast
News
Earnings
Kaleido Biosciences (KLDO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Kaleido Biosciences (OTC:KLDO) Stock
Kaleido Biosciences Stock (OTC: KLDO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Sunday, April 17, 2022
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Shanthi Rexaline
Thursday, April 14, 2022
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
shares of low-float penny stock Kaleido Biosc...
Bill Haddad
Benzinga Pro's Top 5 Stocks To Watch For Thur...
Benzinga Newsdesk
Wednesday, April 13, 2022
Kaleido Biosciences shares are trading higher...
Bill Haddad
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, April 12, 2022
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, April 11, 2022
Kaleido Biosciences shares are trading lower ...
Benzinga Newsdesk
Friday, April 08, 2022
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why
Vandana Singh
Kaleido Biosciences Shares Halted Again On Ci...
Benzinga Newsdesk
Kaleido Biosciences Shares Resume Trading, Do...
Benzinga Newsdesk
Kaleido Biosciences Shares Resume Trading, Do...
Benzinga Newsdesk
Kaleido Biosciences Shares Halted On Circuit ...
Benzinga Newsdesk
Kaleido Biosciences Shares Resume Trading; Do...
Benzinga Newsdesk
Kaleido Biosciences Announces Notice Of Volun...
Benzinga Newsdesk
Kaleido Biosciences Shares Halted On Code New...
Benzinga Newsdesk
Monday, April 04, 2022
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
Benzinga Insights
Chardan Capital Downgrades Kaleido Bioscience...
Benzinga Newsdesk
Friday, March 11, 2022
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Friday, February 25, 2022
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Friday, February 04, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, February 03, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Monday, January 31, 2022
Chardan Capital Maintains Buy on Kaleido Bios...
Benzinga Newsdesk
Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target
Vandana Singh
Tuesday, January 25, 2022
Kaleido Biosciences Granted U.S. Patent #11,229,660 'Glycan therapeutics and method of treating conditions associated with TMAO'
Charles Gross
Tuesday, January 18, 2022
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Tuesday, January 11, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, January 06, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, December 31, 2021
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Thursday, December 30, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Thursday, December 16, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Monday, December 06, 2021
Kaleido Biosciences Announces Expansion Of Co...
Benzinga Newsdesk
Monday, November 15, 2021
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, November 12, 2021
Chardan Capital Maintains Buy on Kaleido Bios...
Benzinga Newsdesk
Wednesday, November 03, 2021
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Monday, November 01, 2021
Kaleido Biosciences's Return On Capital Employed Insights
Benzinga Insights
Kaleido Biosciences Q3 EPS $(0.54) Up From $(...
Benzinga Newsdesk
Tuesday, October 19, 2021
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Morgan Stanley Downgrades Kaleido Biosciences...
Benzinga Newsdesk
Friday, October 08, 2021
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Shanthi Rexaline
Thursday, October 07, 2021
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Shanthi Rexaline
Wednesday, October 06, 2021
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Shanthi Rexaline
36 Biggest Movers From Yesterday
Lisa Levin
Tuesday, October 05, 2021
Why Did Kaleido Shares Plunge 10% On Tuesday?
Vandana Singh
Mid-Afternoon Market Update: Dow Jumps 450 Points; Comtech Telecommunications Shares Slide
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Show More